Immune Checkpoint Inhibitor‐Induced Diabetic Ketoacidosis in a Patient With Pre‐Existing Type 2 Diabetes: A Case Report

Lingfen Zeng, Jieming Sun

doi:10.1002/ccr3.73834

CrossrefInfokort

Immune Checkpoint Inhibitor‐Induced Diabetic Ketoacidosis in a Patient With Pre‐Existing Type 2 Diabetes: A Case Report

Lingfen Zeng, Jieming Sun

Clinical Case Reports · 2026-11 · 14 (11)

DOI: 10.1002/ccr3.73834 ↗

Abstract Bibliografiske oplysninger

Abstract

ABSTRACT Immune checkpoint inhibitors (ICIs) may cause rare life‐threatening ICI‐associated diabetes mellitus. We report a 60‐year‐old Chinese male with pre‐existing type 2 diabetes who developed toripalimab‐induced diabetic ketoacidosis after 3 treatment cycles. He also had toripalimab‐related hyperthyroidism. Clinicians should closely monitor plasma glucose during and after ICI therapy.

Bibliografiske oplysninger

Forfattere: Lingfen Zeng, Jieming Sun
Tidsskrift: Clinical Case Reports
Udgivelsesår: 2026
Bind / nummer: 14 / 11
Forlag: Wiley
DOI: 10.1002/ccr3.73834
ISSN: 2050-0904; 2050-0904
Kilde: Crossref

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.